BRL-37344是一種藥物,分子式C19H22ClNO4,為β-3腎上腺素受體選擇性激動劑,[1]已針對各種生物醫學的應用開展了相關研究,但尚未提供臨床使用。[2][3][4][5][6][7]
Quick Facts 臨床資料, 商品名(英語:Drug nomenclature) ...
BRL-37344 |
|
商品名 | BRL-37344 |
---|
|
法律規範 |
- 美:Investigational New Drug
|
---|
|
2-{4-[(2R)-2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl]phenoxy}acetic acid
|
CAS號 | 114333-71-0 |
---|
PubChem CID | |
---|
CompTox Dashboard (EPA) | |
---|
|
化學式 | C19H22ClNO4 |
---|
摩爾質量 | 363.8 |
---|
3D模型(JSmol) | |
---|
C[C@H](CC1=CC=C(C=C1)OCC(=O)O)NC[C@@H](C2=CC(=CC=C2)Cl)O
|
InChI=1S/C19H22ClNO4/c1-13(21-11-18(22)15-3-2-4-16(20)10-15)9-14-5-7-17(8-6-14)25-12-19(23)24/h2-8,10,13,18,21-22H,9,11-12H2,1H3,(H,23,24)/t13-,18+/m1/s1 Key:ZGGNJJJYUVRADP-ACJLOTCBSA-N
|
Close
Napp A, Brixius K, Pott C, Ziskoven C, Boelck B, Mehlhorn U, et al. Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium. Journal of Cardiac Failure. February 2009, 15 (1): 57–67. PMID 19181295. doi:10.1016/j.cardfail.2008.08.006.
Xu Z, Wu J, Xin J, Feng Y, Hu G, Shen J, et al. β3-adrenergic receptor activation induces TGFβ1 expression in cardiomyocytes via the PKG/JNK/c-Jun pathway. Biochemical and Biophysical Research Communications. September 2018, 503 (1): 146–151. PMID 29859189. doi:10.1016/j.bbrc.2018.05.200.
Grzelka K, Gawlak M, Czarzasta K, Szulczyk P. β3-adrenergic receptor stimulation on the resting holding current of medial prefrontal cortex pyramidal neurons in young rats. Neuroscience Letters. April 2019, 698: 192–197. PMID 30641111. doi:10.1016/j.neulet.2019.01.022.
Fellous TG, Redpath AN, Fleischer MM et al. Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery. npj Regen Med 2020; 5: 3. doi:10.1038/s41536-020-0088-1